The TME of HCC, comprising tumour cells, a variety of immune cells (e.g. CD8+ T cells) and stromal cells, exhibits significant heterogeneity, which is a major contributor to HCC metastasis, relapse and drug resistance.269. This evidence concerns the gene CD8A and hepatocellular carcinoma.